Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Result of AGM

21 Apr 2011 14:42

RNS Number : 3797F
Flying Brands Limited
21 April 2011
 



 

21 April 2011

 

FLYING BRANDS LIMITED

 

ANNUAL GENERAL MEETING

 

 

The Company's Annual General Meeting was held on 21 April 2011 where the following Resolutions were proposed and carried:

 

Resolution 1

To receive and adopt the Report and Accounts for the 52 weeks ending 31 December 2010

 

Proxies:

Total proxy votes cast were 5,281,027 of which 5,262,522 (99.7%) were in favour; 5,016 (0.1%) against, and 11,339 (0.2 %) at discretion. 2,330 votes were withheld.

 

 

Resolution 2

To receive and approve the Remuneration Committee Report for the 52 weeks ended 31 December 2010

 

Proxies:

Total proxy votes cast were 5,281,027, of which 4,141,230 (99.4%) were in favour; 12,838 (0.3%) against, and 11,639 (0.3%) at discretion. 1,115,500 votes were withheld.

 

 

Resolution 3

To declare a full net dividend of 2.4p per share with a final dividend of 0.8p

 

Proxies:

Total proxy votes cast were 5,281,027, of which 5,268,968 (99.8%) were in favour; 400 against, and 11,339 (0.2%) at discretion. 500 votes were withheld.

 

 

Resolution 4

To re-elect Mr SS Cook as a Director

 

Proxies:

Total proxy votes cast were 5,281,027, of which 3,725,145 (70.6%) were in favour; 1,542,824 (29.2%) against, and 11,339 (0.2%) at discretion. 1,899 votes were withheld.

 

  

Resolution 5

To elect Mr FG Voisin as a Director

 

Proxies:

Total proxy votes cast were 5,281,027, of which 5,259,371 (99.6%) were in favour; 5,598 (0.1%) against, and 14,339 (0.3%) at discretion. 1,899 votes were withheld.

 

 

Resolution 6

To re-appoint KPMG, Channel Islands, as auditors of the Company and the Directors be authorised to fix their remuneration.

 

Proxies:

Total proxy votes cast were 5,281,027, of which 5,254,941 (99.5%) were in favour; 10,028 (0.2%) against, and 14,339 (0.3%) at discretion. 1,899 votes were withheld.

 

  

Special Resolution 7

To authorise the Company to make market purchases of its own shares

Proxies:

Total proxy votes cast were 5,281,027, of which 5,255,614 (99.5%) were in favour; 8,815 (0.2%) against, and 14,589 (0.3%) at discretion. 2,189 votes were withheld.

 

 

 

Special Resolution 8

To authorise the Company to allot shares without rights of pre-emption

 

Poll result:

Total votes cast were 16,034,811, of which 13,975,005 (87.2%) were in favour and 2,055,617 (12.8%)against. 4,189 votes were withheld.

 

 

 

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Anthony Gee, Finance Director

 

Smithfield Consultants 020 7360 4900John Kiely

 

Notes to editors

 

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand and multi channel home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions: 

 

·; Gifts (Flying Flowers, Flowers Direct and Drake Algar  making the company one of the UK'sleading florists)

·; Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Garden Centre Online, an internet retailer of garden hardware products)

·; Entertainment (Listen2, a mail order audio books, nostalgic music, DVD and video home shopping retailer)

·; Dealtastic (Deal a day website)

More information can be found at: www.flyingbrands.com

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGIBMJTMBJTBAB
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.